Pro-ocular™ topical gel

DRUG2 trials

Sponsors

Glia, LLC, PharmaDax Inc.

Conditions

Chronic Ocular Graft-versus-host DiseaseDry Eye SyndromeKeratoconjunctivitis Sicca

Phase 2

Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.

CompletedNCT03990051

Glia, LLCChronic Ocular Graft-versus-host Disease

Start: 2019-10-17End: 2021-11-19Updated: 2025-05-06

Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study

PharmaDax Inc.Dry Eye Syndrome, Keratoconjunctivitis Sicca

Start: 2021-05-20End: 2021-12-30Target: 80Updated: 2021-05-14